ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1403	National Cancer Institute	Html	en	Fatigue (PDQ®)–Patient Version	Expert-reviewed information summary about fatigue, a condition marked by extreme tiredness and inability to function because of lack of energy, often seen as a complication of cancer or its treatment.	red blood cells 0.552402 Different cancer treatments 0.470429 biologic therapy 0.483312 severe fatigue 0.621555 cancer treatment-related fatigue 0.636294 blood tests 0.461178 fatigue assessment 0.562053 cancer-related fatigue 0.677281 body 0.472364 PDQ cancer information 0.534931 cancer therapy 0.461118 fatigue 0.963302 health care team 0.495127 clinical trials 0.513612 cancer information summary 0.506469 energy 0.466768 clinical trial 0.50167 cancer survivors 0.464912 fatigue check 0.563522 patients 0.726236 cancer patients 0.600118 moderate-to-severe fatigue 0.551795 cancer diagnosis 0.463516 NCI PDQ cancer 0.473596 radiation therapy 0.547137	cancer fatigue 0.617229 Cancer Patients section 0.478138 problems 0.464163 cancer treatments 0.538547 long-term fatigue 0.571932 therapy cause fatigue 0.601171 anemia-related fatigue 0.55909 Cancer Information Service 0.463488 daily activities 0.501915 National Cancer Institute 0.509064 physical fatigue 0.587544 Palliative Care Editorial 0.466038 Fatigue symptoms 0.572267 advanced cancer 0.469881 Cancer Care page 0.459216 breast cancer 0.487366 Care Editorial Board 0.466889 PDQ summary 0.463007 attention fatigue 0.572542 cancer clinical trials 0.461489 mental fatigue 0.586619 cancer information summaries 0.462137 comprehensive cancer information 0.462211 cancer 0.850092	CLICK HERE
1509	National Cancer Institute	Html	en	Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.	actuarial survival rate 0.630338 significantly higher incidence 0.497662 survival rates 0.647886 excellent survival rates 0.613575 ovarian cystic neoplasms 0.524669 large series 0.505974 advanced-stage tumors 0.534809 survival rate 0.991192 serous tumors 0.508069 aggressive cytoreductive surgery 0.508958 intraperitoneal disease 0.508061 gross residual tumor 0.624183 DNA ploidy 0.473971 presumed localized tumors 0.627355 primary serous tumor 0.543013 patients 0.874529 gross residual disease. 0.554008 small bowel obstruction 0.517717 20-year survival rates 0.623524 total abdominal hysterectomy 0.500134 malignant potential tumors 0.654434 epithelial ovarian cancers 0.560469 positive lymph nodes 0.513754 secondary cytoreductive procedure 0.496028 malignant invasive carcinomas 0.598953	Oncology Group study 0.492475 borderline ovarian tumors 0.602765 early-stage disease 0.53696 borderline tumors 0.543947 7-year survival rate 0.610698 aneuploid tumors 0.485651 low malignant potential 0.549837 gross residual disease 0.749508 tumor recurrence 0.473805 so-called invasive implants 0.548607 low malignant potential. 0.544407 invasive tumors 0.531513 negative lymph nodes 0.509204 radiation therapy alters 0.492888 borderline tumor 0.475678 d’Obstetrique Annual Report 0.515222 tumor reductive surgery 0.541448 aneuploid invasive implants 0.511492 invasive implants 0.72297 life table analysis 0.517429 tumors 0.678345 completely resected tumor 0.568634 residual tumor 0.843362 large prospective study. 0.509685	CLICK HERE
1575	National Cancer Institute	Html	en	Primary CNS Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of primary CNS lymphoma.	treatment 0.59441 malignant tumor cells 0.410902 cancer treatment 0.387562 magnetic resonance imaging 0.302981 AIDS-Related Lymphoma Treatment 0.38242 cancer cells 0.552497 diagnose primary CNS 0.376869 cancer spreads 0.314799 body 0.390696 chemotherapy 0.325347 Cancer Information Service 0.293659 PDQ cancer information 0.395799 treatment clinical trials 0.330856 National Cancer Institute 0.418327 clinical trials 0.79992 spinal cord 0.477649 normal cells 0.306785 CNS lymphoma spreads 0.36676 cancer information summary 0.355271 high-dose chemotherapy 0.312805 clinical trial 0.527292 lymph vessels 0.292112 new treatment 0.386702	stem cell transplant 0.3294 detailed pictures 0.29332 patients 0.363752 external radiation therapy 0.330212 blood 0.30715 nuclear magnetic resonance 0.30502 bone marrow 0.337702 PDQ summary 0.321843 brain radiation therapy 0.396953 treatment clinical trial 0.299448 lymphoma cells 0.314276 NCI PDQ cancer 0.30844 tests 0.319628 primary intraocular lymphoma 0.315344 cancer clinical trials 0.309551 metastatic CNS lymphoma 0.367075 radiation therapy 0.605061 treatment options 0.328184 Treatment Editorial Board 0.31416 primary cns 0.98741 cancer 0.865897 standard treatment 0.301659 positron emission tomography 0.306717	CLICK HERE
1602	National Cancer Institute	Html	en	Spirituality in Cancer Care (PDQ®)–Patient Version	Spiritual or religious beliefs and practices help patients, families, and caregivers cope with cancer and spiritual distress. Learn how religious and spiritual needs are met during treatment and improve a patient’s quality of life in this expert-reviewed summary.	cancer treatment 0.522404 religious beliefs 0.681568 different spiritual needs 0.447208 PDQ Spirituality 0.401148 PDQ cancer information 0.786944 health care team 0.714879 spiritual coping 0.379369 clinical trials 0.650438 health care providers 0.685151 cancer information summary 0.61546 clinical trial 0.49863 cancer care 0.577956 breast cancer prevention 0.397717 Important spiritual practices 0.424705 PDQ summaries 0.403088 patients 0.717217 cancer patients 0.380258 latest published information 0.382717 NCI’s PDQ 0.403017 seriously ill patients 0.414358 NCI PDQ cancer 0.529841 spiritual beliefs 0.417232 family caregivers 0.485214 cancer prevention 0.40291	spiritual assessment 0.396713 religious well-being 0.397613 Cancer Information Service 0.434582 PDQ Supportive 0.390304 spiritual well-being 0.502278 patient 0.48208 treatment clinical trials 0.384067 National Cancer Institute 0.634076 PDQ documents 0.389821 health care 0.824046 Palliative Care Editorial 0.492644 spiritual concerns 0.49013 new treatment 0.40429 advanced cancer 0.407938 Cancer Care page 0.435587 PDQ database 0.398527 Care Editorial Board 0.494972 PDQ summary 0.556329 cancer clinical trials 0.438523 cancer information summaries 0.448303 comprehensive cancer information 0.448414 cancer 0.990441 specific religious beliefs 0.408892 spiritual issues 0.481168	CLICK HERE
1757	National Cancer Institute	Html	en	Biological Therapies for Cancer	A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.	red blood cells 0.577776 cancer vaccines 0.49997 certain cells 0.540439 human cells 0.554952 healthy cells 0.559468 immune responses 0.496164 dendritic cells 0.583067 white blood cells 0.751432 activated T cells 0.553284 Targeted Cancer Therapies 0.4932 clinical trials 0.665835 anticancer immune response 0.557063 reproductive cells 0.533783 cancer treatment vaccines 0.521084 stem cells 0.582774 biological therapies 0.676853 biological therapy 0.585141 gene therapy 0.624656 cancer cell surface 0.49085 metastatic breast cancer 0.502756 blood-forming stem cells 0.552734 dead cells 0.564287 oncolytic viruses 0.562901 oncolytic virus therapy 0.524139 breast cancer cells 0.605883	abnormal cells 0.587571 non-Hodgkin lymphoma cells 0.585453 receptor-modified T cells 0.533588 Severe allergic reaction 0.495224 cancer cells 0.939837 killer T cells 0.545739 tumour cells 0.53329 immune response 0.649552 antibody-producing cells 0.554007 blood stem cells 0.57668 tumor cells 0.642236 normal cells 0.598729 identical daughter cells 0.56732 immune cells 0.615338 bladder cancer cells 0.599791 laboratory-grown T cells 0.538366 natural killer cells 0.629042 cells 0.962945 cancer clinical trials 0.496931 cytotoxic t cells 0.651132 et al 0.571194 genetically modified cells 0.552195 hematopoietic stem cells 0.563457 immortal hybridoma cells 0.568993	CLICK HERE
1776	National Cancer Institute	Html	es	La nutrición en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los problemas de nutrición que se presentan en pacientes de cáncer.	Oncology Nutrition Dietetic 0.794305 Nutrition risk screening 0.380015 Perioperative nutrition support 0.325434 August DA 0.321534 Bergerson S 0.42802 medical oncology patients 0.319644 American Cancer Society 0.354235 Malnutrition Screening Tool 0.336109 American Society 0.333545 Adult Oncology Patient 0.321746 Cancer Res 0.323371 nutrition interventions across 0.325357 Leser M 0.456946 cancer patients 0.534602 Hematol Oncol Clin 0.319076 Enteral Nutrition 0.453095 oncology patient 0.475881 Parenter Enteral Nutr 0.377081 Nutrition Risk Screening-2002 0.325017 nutrition therapy 0.376862 pacientes quizás 0.322377 Nutrition Dietetic Practice 0.754692 Medical nutrition therapy 0.368433 Subjective Global Assessment 0.322733 terapia nutricional 0.340919	surgical oncology patients 0.340122 clinical practice 0.555659 Radiation Oncology Nursing 0.334481 Care Cancer 0.324544 Academy’s Oncology Nutrition 0.372909 Dietetic Practice Group 0.607536 nutrition risk 0.383416 Modern Nutrition 0.321534 Oncology Nutrition Evidence 0.344953 Oncology Nursing Practice 0.345995 Top Clin Nutr 0.321751 Nutrition assessment 0.344971 nutrition impact symptoms 0.345866 Clin Nutr 0.326461 cancer cachexia 0.388006 Clinical Nutrition 0.351661 Clin Oncol 0.323666 nutrition support therapy 0.32555 Ledesma N 0.427589 Oncology Nursing Society 0.390831 Oncology Nutrition 0.930511 Oncology Nursing 0.416659 Patient-Generated Subjective Global 0.319243 Nutrition management 0.340043	CLICK HERE
1785	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	adjustment disorders 0.371593 psychologic distress screening 0.379318 brief screening 0.406438 NCCN's rapid screening 0.36439 Sin sufrimiento 0.48459 psychological distress 0.370051 distress thermometer 0.532993 Cancer Therapy 0.378399 with early 0.358435 National Comprehensive Cancer 0.924903 Cancer Network Distress 0.416524 self-rating depression scale 0.589802 major depression 0.374428 Jacobsen PB 0.439029 Cancer Center 0.427766 Manual Diagnóstico 0.368702 mood states 0.377645 Natl Cancer Inst 0.393821 trastornos mentales 0.667498 Comprehensive Cancer Network 0.926182 rapid screening 0.44139 with cancer 0.88971 psychologic distress 0.551057 Pain Symptom Manage 0.380417 Hegel MT 0.363843	Akechi T 0.365541 Zung Self-Rating Depression 0.495839 Cancer anxiety 0.395937 American Psychiatric Association 0.655757 hospital anxiety 0.404002 Memorial Sloan-Kettering Cancer 0.384863 with newly 0.361717 mammography among screening 0.361533 Oxford University 0.368144 Johns Hopkins Cancer 0.382693 Patient With Cancer 0.418527 New York 0.365014 Community Cancer Care 0.386652 bone marrow transplant 0.361659 Brief Symptom Inventory 0.536917 newly diagnosed breast 0.450645 Clin Oncol 0.474801 Collins ED 0.360494 Kornblith AB 0.373648 depression scale 0.783205 Trask PC 0.363008 newly diagnosed 0.546482 sufrimiento extremo 0.559882 Holland JC 0.426093	CLICK HERE
2031	National Cancer Institute	Html	es	Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación.	Glándula tiroidea hiperactiva 0.562015 maligna.Molas invasoras 0.545444 siguientes procedimientos 0.560552 estadio iv 0.537226 siguientes aspectos 0.546924 tumores trofoblásticos epitelioides 0.805684 molas invasoras 0.909175 vía oral 0.5248 rayos x 0.529833 enlace drugs approved 0.541637 gonadotropina coriónica huma 0.544512 Gestational Trophoblastic Disease 0.542392 National Cancer Institute 0.526399 ecografía transvaginal 0.535921 siguientes riesgos 0.522487 Instituto Nacional 0.591908 áreas anormales.ampliar examen 0.55209	cuerpo elabora hormona 0.593063 PDQ Tratamiento 0.555876 gestación causa efectos 0.735263 molares.ampliar dilatación 0.527024 partes distantes 0.78863 siguientes factores 0.551671 Physician Data Query 0.592879 estadio i 0.537379 último panel 0.524777 estadio iii 0.537123 término enfermedad 0.57453 siguientes operaciones 0.536826 histerectomía laparoscópica total.Ampliar 0.550873 siguientes enlaces 0.525533 histerectomía abdominal 0.531238 siguientes pruebas 0.60278	CLICK HERE
15636	National Cancer Institute	Html	null	Step 6: Post-Award Administration	Information on numerous requirements that must be met in order to to be in compliance with NIH policy after receiving an award. This includes implementing monitoring systems and keeping financial and programmatic records.			CLICK HERE
16254	National Cancer Institute	Html	es	Genómica del cáncer	La investigación de fundamentos genéticos del cáncer ha mejorado nuestro entendimiento de la biología del cáncer y ha conducido a nuevos métodos de diagnosticar y tratar la enfermedad.	colores vibrantes 0.499759 programas de investigación 0.654055 posibles genes 0.505721 próxima generación 0.497158 prácticas de participación 0.488897 cambios genómicos que 0.533603 NCI al hacerlos 0.685799 gen braf 0.523508 cáncer y programas 0.967985 proteínas. el nci 0.703749 gen her2 0.525613 investigadores representaciones 0.514115 facilidad de acceso 0.490645 alta calidad 0.874691 línea germinal y exposiciones 0.549891	el instituto nacional 0.489007 cuáles tratamientos 0.520412 pequeño porcentaje 0.500295 Genoma Humano 0.547332 pacientes correctos 0.574878 tratamientos en investigación 0.520771 genes candidatos 0.501572 tratamientos correctos 0.52447 Estudios Clínicos del NCI 0.817174 determinada terapia 0.501736 rasgos genómicos y el 0.775836 mutaciones impulsoras 0.525134 la investigación aplicable 0.503499 datos estén 0.521046	CLICK HERE